2024

  • Cayla, M., Spanos C., McWilliam K., Waskett E., Rappsilber J., Matthews K.R., 2024. Differentiation granules, a dynamic regulator of T. brucei development. Nat Commun 15, 2972 (2024). https://doi.org/10.1038/s41467-024-47309-1

2022

  • Cayla, M., Nievas, Y.R., Matthews, K.R., Mottram, J.C., 2022. Distinguishing functions of trypanosomatid protein kinases. Trends in Parasitology 38, 950–961. https://doi.org/10.1016/j.pt.2022.08.009

2021

  • F. Rojas, M. Cayla, K. R. Matthews. Basement membrane proteins as a substrate for efficient trypanosoma brucei differentiation in vitro. PLoS Neglected Tropical Diseases 2021, 15(4):e0009284. DOI: 10.1371/journal.pntd.0009284, PMID: 33909626, PMCID: PMC8109799.

2020

  • M. Cayla, K. R. Matthews, A. C. Ivens. A global analysis of low-complexity regions in the Trypanosoma brucei proteome reveals enrichment in the C-terminus of nucleic acid binding proteins providing potential targets of phosphorylation. Wellcome Open Research 2020, 5:219. DOI: 10.12688/wellcomeopenres.16286.2.
  • M. Cayla, L. McDonald, P. MacGregor, K. R. Matthews. An atypical DYRK kinase connects quorum-sensing with posttranscriptional gene regulation in Trypanosoma brucei. eLife 2020, 9:1-33. DOI: 10.7554/eLife.51620.
  • B. Szöőr & M. Cayla. Gel-Based Methods for the Investigation of Signal Transduction Pathways in Trypanosoma brucei. Methods in molecular biology (Clifton, N.J.) 2020, 2116:497-522. DOI: 10.1007/978-1-0716-0294-2_30.

2019

  • M. Cayla, F. Rojas, E. Silvester, F. Venter, K. R. Matthews. African trypanosomes. Parasites and Vectors 2019. DOI: 10.1186/s13071-019-3355-5. (Review article)

2018

  • L. McDonald, M. Cayla, A. Ivens, B. Mony, P. MacGregor, E. Silvester, K. McWilliam, K. R. Matthews. Non-linear hierarchy of the quorum sensing signalling pathway in bloodstream form African trypanosomes. PLOS Pathogens 2018 June. DOI: https://doi.org/10.1371/journal.ppat.1007145.

2014

  • M. Cayla, N. Rachidi, D. Schmidt-Arras, H. Rosenqvist, M. Wiese, and G.F. Späth. Transgenic Analysis of the Leishmania MAP Kinase MPK10 Reveals an Auto-inhibitory Mechanism Crucial for Stage-Regulated Activity and Parasite Viability. PLoS Pathogens 2014 Sep 18;10(9):e1004347. DOI: 10.1371/journal.ppat.1004347. eCollection 2014.
  • M. Dacher, P. Pescher, O. Leclercq, E. Prina, M. Cayla, M.A. Morales, A. Descoteaux, G.F. Späth. Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses. Molecular Microbiology 2014 Jul;93(1):146-66. DOI: 10.1111/mmi.12648. Epub 2014 Jun 3.
  • M.C. Marinozzi, L. Vergoz, T. Rybkine, S. Ngo, S. Bettoni, M. Cayla, F. Tabarin, M. Jablonski, C. Hue, R. Smith, M. Noris, L. Halbwachs-Mecarelli, R. Donatelli, V. Fremeaux-Bacchi, L.T. Roumenina. Complement factor b mutations in atypical hemolytic uremic syndrome-disease-relevant or benign? Journal of the American Society of Nephrology 2014 Sep;25(9):2053-65. DOI: 10.1681/ASN.2013070796. Epub 2014 Mar 20.

2009

  • L.T. Roumenina, M. Jablonski, C. Hue, J. Blouin, J. D. Dimitrov, M.A. Dragon-Durey, M. Cayla, W.H. Fridman, M.A. Macher, D. Ribes, L. Moulonguet, L. Rostaing, S.C. Satchel, P.W. Mathieson, C. Sautes–Fridman, C. Loirat, C.H. Regnier, L. Halbwachs-Mecarelli, V. Fremeaux-Bacchi. Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood 2009 Sep 24;114(13):2837-45. DOI: 10.1182/blood-2009-01-197640.